ABQ-88485-03691
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 809 / CO
- Registered
- 2021-11-16
- Relationship
- Child or adolescent in my care
- Guardian
- YR6-17959-38223
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-16
Registered in v-safe
-
2021-11-16
Dose 1 — Pfizer-BioNTech
- 2021-11-16
- 2021-11-17
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-12-02
-
2021-12-07
Dose 2 — Pfizer-BioNTech
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
-
2022-01-04
Survey response — day 28, dose 2, dependentMedDRA: Aphonia, Cough, Dyspnoea, Headache, SARS-CoV-2 test — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, headache , sob, lost voice -pcr covid test pendingMedDRA releases: 2024-11 · check-in free text available
- 2022-01-11
- 2022-01-18
- 2022-03-10
- 2022-06-07
- 2022-12-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-16 | Pfizer-BioNTech | No |
| 2 | 2021-12-07 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 2, dependent
Symptoms: Cough, headache , sob, lost voice -pcr covid test pending
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphonia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release